[{"Assets_0_Q2_USD":1724237000.0,"EarningsPerShareDiluted_2_Q2_USD":2.61,"EarningsPerShareDiluted_1_Q2_USD":1.43,"EarningsPerShareBasic_2_Q2_USD":2.65,"EarningsPerShareBasic_1_Q2_USD":1.46,"StockholdersEquityConverted_0_Q2_USD":171549000.0,"StockholdersEquity_0_Q2_USD":171246000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":86215000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":86210000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":87594000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":87615000.0,"NetIncomeLossConverted_1_Q2_USD":125706000.0,"NetIncomeLossConverted_2_Q2_USD":228387000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":171480000.0,"CommonStockSharesOutstanding_0_Q2_shares":86103000.0,"CommonStockSharesConverted_0_Q2_shares":105478000.0,"RevenuesConverted_1_Q2_USD":620103000.0,"RevenuesConverted_2_Q2_USD":1196159000.0,"Ticker":"IDXX","CIK":"874716","name":"IDEXX LABORATORIES INC \/DE","OfficialName":"IDEXX Laboratories Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"42180715521.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"SP500","filed":"20190801"}]